5/28
12:07 pm
clnn
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Medium
Report
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
5/28
07:30 am
clnn
Clene Provides Update on Its NIH-Funded Expanded Access Program for CNM-Au8® in ALS (ACT-EAP)
Medium
Report
Clene Provides Update on Its NIH-Funded Expanded Access Program for CNM-Au8® in ALS (ACT-EAP)
5/23
10:39 am
clnn
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $5.00 price target on the stock.
Medium
Report
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $5.00 price target on the stock.
5/15
06:49 am
clnn
NeuroSense taps PhaseV's ML tech for Phase III ALS trial analysis [Yahoo! Finance]
Low
Report
NeuroSense taps PhaseV's ML tech for Phase III ALS trial analysis [Yahoo! Finance]
5/14
08:15 am
clnn
Clene to Present at Upcoming May Conferences [Yahoo! Finance]
Medium
Report
Clene to Present at Upcoming May Conferences [Yahoo! Finance]
5/14
08:00 am
clnn
Clene to Present at Upcoming May Conferences
Medium
Report
Clene to Present at Upcoming May Conferences
5/8
11:53 am
clnn
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Low
Report
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
5/8
08:21 am
clnn
Clene Reports First Quarter 2024 Financial Results and Recent Operating Highlights [Yahoo! Finance]
Medium
Report
Clene Reports First Quarter 2024 Financial Results and Recent Operating Highlights [Yahoo! Finance]
5/8
08:00 am
clnn
Clene Reports First Quarter 2024 Financial Results and Recent Operating Highlights
Low
Report
Clene Reports First Quarter 2024 Financial Results and Recent Operating Highlights
5/1
08:39 am
clnn
IBN Announces From Lab to Launch Podcast Featuring Clene Inc. CEO Rob Etherington [Yahoo! Finance]
Medium
Report
IBN Announces From Lab to Launch Podcast Featuring Clene Inc. CEO Rob Etherington [Yahoo! Finance]
5/1
08:30 am
clnn
IBN Announces From Lab to Launch Podcast Featuring Clene Inc. CEO Rob Etherington
Medium
Report
IBN Announces From Lab to Launch Podcast Featuring Clene Inc. CEO Rob Etherington
4/30
05:35 am
clnn
‘Liquid gold' could bring new hope to multiple sclerosis patients, study suggests: ‘Profound benefit' [FOX News]
High
Report
‘Liquid gold' could bring new hope to multiple sclerosis patients, study suggests: ‘Profound benefit' [FOX News]
4/23
09:54 am
clnn
Bullish Clene Insiders Loaded Up On US$9.58m Of Stock [Yahoo! Finance]
Low
Report
Bullish Clene Insiders Loaded Up On US$9.58m Of Stock [Yahoo! Finance]
4/17
03:26 pm
clnn
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Low
Report
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
4/16
05:26 pm
clnn
Clene stock rallies 52% post-market on MS drug data [Seeking Alpha]
High
Report
Clene stock rallies 52% post-market on MS drug data [Seeking Alpha]
4/16
04:19 pm
clnn
Evidence for Clene's CNM-Au8® as a Treatment for Repair and Remyelination in Multiple Sclerosis Presented in the Emerging Science Session at the 2024 American Academy of Neurology Annual Meeting [Yahoo! Finance]
High
Report
Evidence for Clene's CNM-Au8® as a Treatment for Repair and Remyelination in Multiple Sclerosis Presented in the Emerging Science Session at the 2024 American Academy of Neurology Annual Meeting [Yahoo! Finance]
4/16
04:01 pm
clnn
Evidence for Clene’s CNM-Au8® as a Treatment for Repair and Remyelination in Multiple Sclerosis Presented in the Emerging Science Session at the 2024 American Academy of Neurology Annual Meeting
Medium
Report
Evidence for Clene’s CNM-Au8® as a Treatment for Repair and Remyelination in Multiple Sclerosis Presented in the Emerging Science Session at the 2024 American Academy of Neurology Annual Meeting
3/20
08:32 am
clnn
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $5.00 price target on the stock.
Low
Report
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $5.00 price target on the stock.
3/19
08:45 am
clnn
IBN Announces First in Human Podcast Featuring Clene Inc. CEO Rob Etherington [Yahoo! Finance]
Low
Report
IBN Announces First in Human Podcast Featuring Clene Inc. CEO Rob Etherington [Yahoo! Finance]
3/19
08:30 am
clnn
IBN Announces First in Human Podcast Featuring Clene Inc. CEO Rob Etherington
Medium
Report
IBN Announces First in Human Podcast Featuring Clene Inc. CEO Rob Etherington
3/18
03:11 pm
clnn
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Medium
Report
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
3/15
08:23 am
clnn
Clene Announces Peer-Reviewed Publication Characterizing the Protein Corona of the Investigational Neurodegenerative Disease Drug, CNM-Au8® [Yahoo! Finance]
Low
Report
Clene Announces Peer-Reviewed Publication Characterizing the Protein Corona of the Investigational Neurodegenerative Disease Drug, CNM-Au8® [Yahoo! Finance]
3/15
08:00 am
clnn
Clene Announces Peer-Reviewed Publication Characterizing the Protein Corona of the Investigational Neurodegenerative Disease Drug, CNM-Au8®
Medium
Report
Clene Announces Peer-Reviewed Publication Characterizing the Protein Corona of the Investigational Neurodegenerative Disease Drug, CNM-Au8®
3/13
08:12 am
clnn
Clene Reports Full Year 2023 Financial Results and Recent Operating Highlights [Yahoo! Finance]
Medium
Report
Clene Reports Full Year 2023 Financial Results and Recent Operating Highlights [Yahoo! Finance]
3/13
08:00 am
clnn
Clene Reports Full Year 2023 Financial Results and Recent Operating Highlights
Medium
Report
Clene Reports Full Year 2023 Financial Results and Recent Operating Highlights